Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61049-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329394688983040 |
|---|---|
| author | Xiangling Xiao Jie Shi Chuan He Xia Bu Yishuang Sun Minling Gao Bolin Xiang Wenjun Xiong Panpan Dai Qi Mao Xixin Xing Yingmeng Yao Haisheng Yu Gaoshan Xu Siqi Li Yan Ren Baoxiang Chen Congqing Jiang Geng Meng Yu-Ru Lee Wenyi Wei Gordon J. Freeman Conghua Xie Jinfang Zhang |
| author_facet | Xiangling Xiao Jie Shi Chuan He Xia Bu Yishuang Sun Minling Gao Bolin Xiang Wenjun Xiong Panpan Dai Qi Mao Xixin Xing Yingmeng Yao Haisheng Yu Gaoshan Xu Siqi Li Yan Ren Baoxiang Chen Congqing Jiang Geng Meng Yu-Ru Lee Wenyi Wei Gordon J. Freeman Conghua Xie Jinfang Zhang |
| author_sort | Xiangling Xiao |
| collection | DOAJ |
| format | Article |
| id | doaj-art-735e4c52e3b6462f93f31432d8de03b0 |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-735e4c52e3b6462f93f31432d8de03b02025-08-20T03:47:16ZengNature PortfolioNature Communications2041-17232025-06-011611110.1038/s41467-025-61049-wAuthor Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapyXiangling Xiao0Jie Shi1Chuan He2Xia Bu3Yishuang Sun4Minling Gao5Bolin Xiang6Wenjun Xiong7Panpan Dai8Qi Mao9Xixin Xing10Yingmeng Yao11Haisheng Yu12Gaoshan Xu13Siqi Li14Yan Ren15Baoxiang Chen16Congqing Jiang17Geng Meng18Yu-Ru Lee19Wenyi Wei20Gordon J. Freeman21Conghua Xie22Jinfang Zhang23Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Biology, University of CopenhagenExperiment Center for Science and Technology, Shanghai University of Traditional Chinese MedicineDepartment of Colorectal and Anal Surgery, Low Rectal Cancer Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan UniversityDepartment of Colorectal and Anal Surgery, Low Rectal Cancer Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan UniversityCollege of Veterinary Medicine, China Agricultural UniversityInstitute of Biomedical Sciences, Academia SinicaDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan UniversityDepartment of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan Universityhttps://doi.org/10.1038/s41467-025-61049-w |
| spellingShingle | Xiangling Xiao Jie Shi Chuan He Xia Bu Yishuang Sun Minling Gao Bolin Xiang Wenjun Xiong Panpan Dai Qi Mao Xixin Xing Yingmeng Yao Haisheng Yu Gaoshan Xu Siqi Li Yan Ren Baoxiang Chen Congqing Jiang Geng Meng Yu-Ru Lee Wenyi Wei Gordon J. Freeman Conghua Xie Jinfang Zhang Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy Nature Communications |
| title | Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| title_full | Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| title_fullStr | Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| title_full_unstemmed | Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| title_short | Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| title_sort | author correction erk and usp5 govern pd 1 homeostasis via deubiquitination to modulate tumor immunotherapy |
| url | https://doi.org/10.1038/s41467-025-61049-w |
| work_keys_str_mv | AT xianglingxiao authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT jieshi authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT chuanhe authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT xiabu authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT yishuangsun authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT minlinggao authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT bolinxiang authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT wenjunxiong authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT panpandai authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT qimao authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT xixinxing authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT yingmengyao authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT haishengyu authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT gaoshanxu authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT siqili authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT yanren authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT baoxiangchen authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT congqingjiang authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT gengmeng authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT yurulee authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT wenyiwei authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT gordonjfreeman authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT conghuaxie authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy AT jinfangzhang authorcorrectionerkandusp5governpd1homeostasisviadeubiquitinationtomodulatetumorimmunotherapy |